What Happened?
Shares of health coverage company Centene (NYSE: CNC) fell 4.3% in the afternoon session after reports indicated the House Speaker would not permit a vote to renew premium subsidies for the Affordable Care Act (ACA).
Centene, a key provider of government-backed health plans, depends significantly on the ACA marketplace. The potential end of these subsidies, which help lower insurance costs for many individuals, raised concerns about the company's future earnings and enrollment numbers. This development arrived as the health insurance sector was already dealing with the pressure of rising medical expenses that were squeezing profit margins. The combination of these challenges appeared to have influenced investor sentiment.
The shares closed the day at $38.97, down 3.7% from previous close.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Centene? Access our full analysis report here.
What Is The Market Telling Us
Centene’s shares are very volatile and have had 20 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 5 days ago when the stock gained 5.8% on the news that Baird raised its price target on the stock to $36 from $28, though the firm maintained its Neutral rating.
The move from the investment firm suggested an improved outlook on the company's valuation, even as it stopped short of a full recommendation to buy the shares. Adding to the positive sentiment, the Hotchkis & Wiley Mid-Cap Value Fund noted in a recent investor letter that it viewed Centene as an attractive investment. The fund pointed to the company's position as a clear market leader where scale provides a significant competitive edge.
Centene is down 35.6% since the beginning of the year, and at $38.97 per share, it is trading 40.9% below its 52-week high of $65.89 from January 2025. Investors who bought $1,000 worth of Centene’s shares 5 years ago would now be looking at an investment worth $638.46.
Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free for active Edge members and will only take you a second.
